University of the Witwatersrand: Novavax COVID-19 Vaccine Trial Results Show Efficacy Against the B.1.351 Variant in SA Study
May 07, 2021
May 07, 2021
JOHANNESBURG, South Africa, May 7 (TNSJou) -- The University of the Witwatersrand issued the following news:
Results from the initial primary analysis of the Novavax Covid-19 vaccine trial conducted by Wits VIDA in SA have been published.
The New England Journal of Medicine (NEJM) today published findings of the Phase 2b clinical trial conducted in South Africa.
NEJM is recognised as the world's leading medical journal.
Shabir Madhi, Profe . . .
Results from the initial primary analysis of the Novavax Covid-19 vaccine trial conducted by Wits VIDA in SA have been published.
The New England Journal of Medicine (NEJM) today published findings of the Phase 2b clinical trial conducted in South Africa.
NEJM is recognised as the world's leading medical journal.
Shabir Madhi, Profe . . .